These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7504544)

  • 1. Potential mechanisms of action of interferon-alpha in CML.
    Dowding C; Gordon M; Guo AP; Maison D; Osterholz J; Siczkowski M; Goldman J
    Leuk Lymphoma; 1993; 11 Suppl 1():185-91. PubMed ID: 7504544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-alpha and bcr-abl antisense oligodeoxynucleotides in combination enhance the antileukemic effect and the adherence of CML progenitors to preformed stroma.
    Bellucci R; Sala R; De Propris MS; Cordone I; de Fabritiis P
    Leuk Lymphoma; 1999 Nov; 35(5-6):471-81. PubMed ID: 10609784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrin-mediated regulation of hematopoiesis: do BCR/ABL-induced defects in integrin function underlie the abnormal circulation and proliferation of CML progenitors?
    Verfaillie CM; Hurley R; Lundell BI; Zhao C; Bhatia R
    Acta Haematol; 1997; 97(1-2):40-52. PubMed ID: 8980609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fas-mediated modulation of Bcr/Abl in chronic myelogenous leukemia results in differential effects on apoptosis.
    Selleri C; Maciejewski JP; Pane F; Luciano L; Raiola AM; Mostarda I; Salvatore F; Rotoli B
    Blood; 1998 Aug; 92(3):981-9. PubMed ID: 9680367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-alpha effects on stromal compartment of normal and chronic myeloid leukemia hematopoiesis.
    Santucci MA; Soligo D; Pileri S; Zuffa E; Testoni N; Tura S
    Leuk Lymphoma; 1993; 11 Suppl 1():113-8. PubMed ID: 8251886
    [No Abstract]   [Full Text] [Related]  

  • 6. Interferon-alpha induces dendritic cell differentiation of CML mononuclear cells in vitro and in vivo.
    Paquette RL; Hsu N; Said J; Mohammed M; Rao NP; Shih G; Schiller G; Sawyers C; Glaspy JA
    Leukemia; 2002 Aug; 16(8):1484-9. PubMed ID: 12145689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of marrow stroma with interferon-alpha restores normal beta 1 integrin-dependent adhesion of chronic myelogenous leukemia hematopoietic progenitors. Role of MIP-1 alpha.
    Bhatia R; McGlave PB; Verfaillie CM
    J Clin Invest; 1995 Aug; 96(2):931-9. PubMed ID: 7543495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of Fas-mediated apoptosis in the inhibitory effects of interferon-alpha in chronic myelogenous leukemia.
    Selleri C; Sato T; Del Vecchio L; Luciano L; Barrett AJ; Rotoli B; Young NS; Maciejewski JP
    Blood; 1997 Feb; 89(3):957-64. PubMed ID: 9028327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-alpha restores normal beta 1 integrin-mediated inhibition of hematopoietic progenitor proliferation by the marrow microenvironment in chronic myelogenous leukemia.
    Bhatia R; McCarthy JB; Verfaillie CM
    Blood; 1996 May; 87(9):3883-91. PubMed ID: 8611716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon-alpha restores normal adhesion of chronic myelogenous leukemia hematopoietic progenitors to bone marrow stroma by correcting impaired beta 1 integrin receptor function.
    Bhatia R; Wayner EA; McGlave PB; Verfaillie CM
    J Clin Invest; 1994 Jul; 94(1):384-91. PubMed ID: 7518835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonal heterogeneity of dendritic cells derived from patients with chronic myeloid leukemia and enhancement of their T-cells stimulatory activity by IFN-alpha.
    Wang C; Al-Omar HM; Radvanyi L; Banerjee A; Bouman D; Squire J; Messner HA
    Exp Hematol; 1999 Jul; 27(7):1176-84. PubMed ID: 10390193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L-selectin expression is low on CD34+ cells from patients with chronic myeloid leukemia and interferon-a up-regulates this expression.
    Martín-Henao GA; Quiroga R; Sureda A; González JR; Moreno V; García J
    Haematologica; 2000 Feb; 85(2):139-46. PubMed ID: 10681720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of interferon-alpha on cytokine expression by the bone marrow microenvironment--impact on treatment of myeloproliferative disorders.
    Peschel C; Aulitzky WE; Huber C
    Leuk Lymphoma; 1996 Sep; 22 Suppl 1():129-34. PubMed ID: 8951783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-alpha restores the deficient expression of the cytoadhesion molecule lymphocyte function antigen-3 by chronic myelogenous leukemia progenitor cells.
    Upadhyaya G; Guba SC; Sih SA; Feinberg AP; Talpaz M; Kantarjian HM; Deisseroth AB; Emerson SG
    J Clin Invest; 1991 Dec; 88(6):2131-6. PubMed ID: 1721627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stem cell factor as a single agent induces selective proliferation of the Philadelphia chromosome positive fraction of chronic myeloid leukemia CD34(+) cells.
    Moore S; Haylock DN; Lévesque JP; McDiarmid LA; Samels LM; To LB; Simmons PJ; Hughes TP
    Blood; 1998 Oct; 92(7):2461-70. PubMed ID: 9746786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-alpha overrides the deficient adhesion of chronic myeloid leukemia primitive progenitor cells to bone marrow stromal cells.
    Dowding C; Guo AP; Osterholz J; Siczkowski M; Goldman J; Gordon M
    Blood; 1991 Jul; 78(2):499-505. PubMed ID: 1906352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The anti-tumor activities of interferon (IFN)-alpha in chronic myelogenous leukaemia (CML)-derived cell lines depends on the IFN-alpha subtypes.
    Yanai Y; Sanou O; Yamamoto K; Yamauchi H; Ikegami H; Kurimoto M
    Cancer Lett; 2002 Nov; 185(2):173-9. PubMed ID: 12169391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stem cell factor and chronic myeloid leukemia CD34+ cells.
    Moore S; McDiarmid LA; Hughes TP
    Leuk Lymphoma; 2000 Jul; 38(3-4):211-20. PubMed ID: 10830729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms underlying abnormal trafficking of malignant progenitors in chronic myelogenous leukemia. Decreased adhesion to stroma and fibronectin but increased adhesion to the basement membrane components laminin and collagen type IV.
    Verfaillie CM; McCarthy JB; McGlave PB
    J Clin Invest; 1992 Oct; 90(4):1232-41. PubMed ID: 1383271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eilatin: a novel marine alkaloid inhibits in vitro proliferation of progenitor cells in chronic myeloid leukemia patients.
    Einat M; Lishner M; Amiel A; Nagler A; Yarkorli S; Rudi A; Kashman Y; Markel D; Fabian I
    Exp Hematol; 1995 Dec; 23(14):1439-44. PubMed ID: 8542929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.